Clene, Inc. (CLNN)
5.57
+0.24
(+4.50%)
USD |
NASDAQ |
Jun 09, 16:00
5.465
-0.10
(-1.89%)
After-Hours: 20:00
Clene SG&A Expense (Quarterly) : 1.747M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| NovelStem International Corp. | 0.005M |
| Brainstorm Cell Therapeutics, Inc. | 1.284M |
| Precigen, Inc. | 21.05M |
| Summit Therapeutics, Inc. | 62.59M |
| Kezar Life Sciences, Inc. | 5.208M |